Overview
Lobbying Costs
1,250,000€ - 1,499,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
2.5 Fte (5)
Lobbyists with EP accreditation
4
High-level Commission meetings
19
Lobbying Costs over the years
-
Info
Pfizer Inc. (PFE)
EU Transparency Register
4263301811-33 First registered on 18 Dec 2008
Goals / Remit
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
Main EU files targeted
Revision of general EU pharmaceutical legislation, digital health e.g. European Health Data Space, AI Regulation, gene therapy, pharmaceutical strategy, Paediatric & Orphan Review, Vaccination policy, HTA Regulation, Pharmaceuticals in the Environment, IHI and research programs, EU trade negotiations, corporate tax, Covid-19 vaccines & therapeutics procurement, HERA & bio-preparedness.
Address
Head Office
66 Hudson Boulevard E
New York NY 10001
UNITED STATESEU Office
Boulevard de la Plaine 17
Brussels 1050
BELGIUMWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 50% 5 Lobbyists (Full time equivalent)
2.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
4 accreditations were / are live (in bold) for the selected state of 22 Nov 2024
Name Start date End Date Yordan Aleksandrov 01 Jul 2024 01 Jul 2025 Coralie DELETTRE 01 Jul 2024 01 Jul 2025 ANDREA CHIARELLO 29 Jun 2024 29 Jun 2026 Riccardo ROVERA 15 Jun 2024 15 Jun 2026 Riccardo ROVERA 17 Jun 2023 15 Jun 2024 Coralie DELETTRE 30 Jun 2023 29 Jun 2024 ANDREA CHIARELLO 01 Jul 2023 29 Jun 2024 Charles FAID 28 Sep 2023 28 Sep 2024 Yordan Aleksandrov 31 Mar 2023 30 Mar 2024 Mr Victor DE DECKER 18 Oct 2022 21 Jan 2023 Charles FAID 09 Sep 2022 08 Sep 2023 Riccardo ROVERA 01 Jul 2022 17 Jun 2023 ANDREA CHIARELLO 25 Jun 2022 24 Jun 2023 Ms Eva GRUT AANDAHL 25 Mar 2022 25 Mar 2023 Yordan Aleksandrov 24 Mar 2022 24 Mar 2023 Franjo CAIC 07 Jul 2021 21 Sep 2021 ANDREA CHIARELLO 06 Jul 2021 25 Jun 2022 Heike Galbraith 06 Mar 2021 15 Jan 2022 Ms Eva GRUT AANDAHL 06 Mar 2021 05 Mar 2022 ANDREA CHIARELLO 14 Aug 2020 06 Jul 2021 Franjo CAIC 06 Aug 2020 07 Jul 2021 Ms EVA GRUT AANDAHL 12 Feb 2020 01 Mar 2021 Charles FAID 12 Feb 2020 01 Mar 2021 Heike Galbraith 12 Feb 2020 01 Mar 2021 Mr Matthew Thomas CLAY 14 Dec 2019 12 Dec 2020 ANDREA CHIARELLO 06 Sep 2019 14 Aug 2020 Franjo CAIC 22 Aug 2019 06 Aug 2020 Ms EVA GRUT AANDAHL 06 Feb 2019 12 Feb 2020 Charles FAID 06 Feb 2019 12 Feb 2020 Heike Galbraith 06 Feb 2019 12 Feb 2020 Mr Matthew Thomas CLAY 12 Dec 2018 12 Dec 2019 ANDREA CHIARELLO 26 Sep 2018 06 Sep 2019 Ms EVA GRUT AANDAHL 03 Feb 2018 02 Feb 2019 Charles FAID 03 Feb 2018 02 Feb 2019 Heike Galbraith 03 Feb 2018 02 Feb 2019 Mr Matthew Thomas CLAY 09 Jan 2018 12 Dec 2018 ANDREA CHIARELLO 01 Sep 2017 01 Sep 2018 Ms EVA GRUT AANDAHL 21 Feb 2017 03 Feb 2018 Charles FAID 21 Feb 2017 03 Feb 2018 Heike Galbraith 21 Feb 2017 03 Feb 2018 Mr Matthew Thomas CLAY 23 Jan 2017 09 Jan 2018 ANDREA CHIARELLO 30 Sep 2016 01 Sep 2017 Ms EVA GRUT AANDAHL 10 Mar 2016 22 Feb 2017 Charles FAID 10 Mar 2016 22 Feb 2017 Heike Galbraith 10 Mar 2016 22 Feb 2017 Mr Matthew Thomas CLAY 15 Jan 2016 14 Jan 2017 ANDREA CHIARELLO 28 Aug 2015 31 Aug 2016 Ms EVA GRUT AANDAHL 19 Feb 2015 17 Feb 2016 Charles FAID 25 Feb 2015 18 Feb 2016 Heike Galbraith 25 Feb 2015 23 Feb 2016 Mr Matthew Thomas CLAY 09 Jan 2015 07 Jan 2016 Mr Matthew Thomas CLAY 16 Jan 2014 09 Jan 2015 Ms EVA GRUT AANDAHL 14 Feb 2013 13 Feb 2014 Mr Matthew Thomas CLAY 17 Jan 2013 06 Dec 2013 Mr Matthew Thomas CLAY 20 Dec 2011 08 Feb 2013 Complementary Information
5 colleagues are full-time engaged in the Brussels office and spend approx. 50% of their time on activities in scope of the Register.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
In 2023 Pfizer was a member of: EFPIA, Vaccines Europe, EuropaBio, Amcham EU, BusinessEurope, Alliance for Generative Medicine (ARM).
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
1,250,000€ - 1,499,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount fipra 10,000€ - 24,999€ rpp group 50,000€ - 99,999€ zn consulting 50,000€ - 99,999€ evoke incisive health 50,000€ - 99,999€ fleishman-hillard 50,000€ - 99,999€ fti consulting 100,000€ - 199,999€ Intermediaries for current year
Name fti consulting rpp group fleishman-hillard Closed year Costs
1,250,000€ - 1,499,999€
Other financial info
The amount declared in answer (c) includes: relevant percentage of trade associations' work, consultants as declared, percentage of colleagues' fully loaded salary and office expenses.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Pfizer EU website: www.pfizereupolicy.eu
Pfizer EU Twitter account: @PfizerEUPolicyOther activities
None declared
Meetings
Meetings
19 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 02 Mar 2023 Location Pfizer, Grange Castle, Clondalkin, Dublin 22 Subject Introductory meeting Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Paul Moley (Cabinet member)
- Mairead McGuinness (Commissioner)
-
Date 12 Oct 2022 Location Washington, D.C. Subject Exchange on-going cooperation; Europe's Beating Cancer plan - exchange on innovation in the future of cancer treatment and care Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Tove Ernst (Cabinet member)
- Stella Kyriakides (Commissioner)
-
Date 09 Sep 2022 Location Thessaloniki Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
-
Date 26 Nov 2021 Location Videoconference Subject Meeting with CEO of Pfizer Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
-
Date 26 Oct 2021 Location Brussels Subject Pharmaceutical sector – trade related issues Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Caroline Boeshertz (Cabinet member)
- Elina Melngaile (Cabinet member)
- Kevin Keary (Cabinet member)
Other Lobbyists -
Date 18 Oct 2021 Location Phone call Subject Call with Pfizer’s Regional President for Vaccines, Mr. Sinan Atlig, to discuss the implementation of COVID-19 vaccines Advance Purchase Agreement Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Roberto Reig Rodrigo (Cabinet member)
- Giorgios Rossides (Cabinet member)
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
Other Lobbyists -
Date 07 May 2021 Location Puurs, Belgium Subject Site visit and assessment of production capacity and supply chain Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 10 Apr 2021 Location Videocall Subject Vaccine production and deliveries Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 07 Apr 2021 Location Brussels Subject Vaccine delivery schedule for Q2 2021 Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 21 Feb 2021 Location Puurs, Belgium Subject COVID-19 vaccines production Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
-
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists -
Date 27 Nov 2018 Location Brussels Subject EU-US relations, trade aspects of Brexit Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Nele Eichhorn (Cabinet member)
-
Date 29 Nov 2017 Location Brussels Subject Pharmaceutical incentives, antimicrobial resistance Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
Other Lobbyists -
Date 21 Nov 2017 Location Brussels Subject Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC) and patent research exemptions; innovation in the pharmaceutical industry Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Jyrki Katainen (Vice-President)
Other Lobbyists -
Date 01 Sep 2017 Location Cernobbio Subject Exchange of views on the Italian and euro zone economies and priorities for reform Cabinet Cabinet of Commissioner Pierre Moscovici Portfolio Economic and Financial Affairs, Taxation and Customs Attending - Simon O'Connor (Cabinet member)
- Pierre Moscovici (Commissioner)
Other Lobbyists -
Date 14 Jan 2016 Location Brussels Subject AECA Round-Table on “Dealing with Regulatory Burden Cabinet Cabinet of First Vice-President Frans Timmermans Portfolio Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights Attending - Bernardus Smulders (Cabinet member)
Other Lobbyists -
Date 02 Mar 2015 Location Brussels Subject Access to innovative medicine Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 27 Jan 2015 Location Brussels Belgium Subject Introductory meeting Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)